ConditionIron Deficiency Without Anemia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorSwiss Federal Institute of Technology
About this trial
Serum ferritin is a key indicator of body iron stores and is widely used in monitoring iron status. However, oral iron doses can acutely elevate SF levels, potentially biasing assessments of iron stores during supplementation. This study aims to investigate the extent and duration of the acute iron-induced effect on serum ferritin following the administration of a daily iron dose for two months.
Eligibility criteria
Qualifiers
Low iron stores (SF levels < 30 µg/L),
no anemia (Hb > 120 g/L)
no inflammation (CRP < 5 mg/L)
18 to 45 years old.
Disqualifiers
Any chronic or acute disease
Consumption of mineral and vitamin supplements since screening and over the study period
Blood transfusion, blood donation or significant blood loss over the past 4 months,
Pregnant or breastfeeding,
Trial design
Treatments tested in this trial
- ferrous sulfate 80 mg
- ferrous sulfate 160 mg
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov